{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthe-limbic.simplecast.com%2Fepisodes%2Fbreakfast-at-kings-car-t-therapy-in-lupus-7H9t7R9o","width":444,"version":"1.0","type":"rich","title":"Breakfast at King's: CAR-T therapy in lupus","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/e7ce54e7-4eb8-49bf-87d3-38e0d3ede6c5/96f4df40-b774-4a0c-af7a-2d7cd7e60c4f/breakfast-at-king-s.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/87055d4d-98ba-4b20-b126-2efd246369ef\" height=\"200\" width=\"100%\" title=\"Breakfast at King&apos;s: CAR-T therapy in lupus\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Join us for Breakfast at King's - a series of discussions with experts at King's College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!\n\nIn this episode, Dr Chris Wincup discusses a published case series that highlights the potential for CAR T-cell therapy for patients with autoimmune disease. He also describes the long and durable responses being seen with CAR-T cell therapy, hospitalisation requirements for those undergoing therapy, and specific safety considerations (including CRS and ICANS)."}